Globe Life (NYSE:GL) Price Target Raised to $201.00

Globe Life (NYSE:GL) had its price objective boosted by investment analysts at JPMorgan Chase & Co. from $181.00 to $201.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 9.18% from the stock’s previous close.

A number of other equities analysts have also recently commented on GL. Jefferies Financial Group upped their price objective on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. Piper Sandler lifted their target price on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. TD Cowen boosted their target price on Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a research note on Tuesday, June 23rd. Morgan Stanley increased their target price on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a report on Monday, July 6th. Finally, Truist Financial raised their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and an average price target of $186.60.

Globe Life Price Performance

NYSE:GL traded down $0.15 during mid-day trading on Tuesday, reaching $184.09. The stock had a trading volume of 58,562 shares, compared to its average volume of 545,202. The stock has a 50-day simple moving average of $167.16 and a two-hundred day simple moving average of $151.92. The stock has a market capitalization of $14.29 billion, a PE ratio of 12.72 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life has a 12 month low of $120.05 and a 12 month high of $191.55.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the prior year, the firm earned $3.07 earnings per share. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, equities analysts anticipate that Globe Life will post 15.64 earnings per share for the current year.

Insider Buying and Selling at Globe Life

In other Globe Life news, EVP Michael Clay Majors sold 34,000 shares of the stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $153.81, for a total transaction of $5,229,540.00. Following the completion of the sale, the executive vice president directly owned 53,518 shares in the company, valued at approximately $8,231,603.58. This trade represents a 38.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO James Matthew Darden sold 4,663 shares of Globe Life stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the transaction, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $8,994,439.88. This trade represents a 7.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 124,187 shares of company stock valued at $19,529,414. 2.11% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Globe Life

Hedge funds have recently added to or reduced their stakes in the business. SG Americas Securities LLC raised its holdings in Globe Life by 909.6% during the 4th quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock valued at $13,950,000 after acquiring an additional 89,866 shares during the period. Tudor Investment Corp ET AL purchased a new position in shares of Globe Life in the third quarter valued at $7,348,000. Jupiter Asset Management Ltd. purchased a new position in shares of Globe Life in the fourth quarter valued at $2,073,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Globe Life by 34,786.0% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock valued at $123,345,000 after purchasing an additional 879,391 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in Globe Life by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after purchasing an additional 86,349 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.